Home | Publications | Research (R&D) | Pipeline place holder

Research & Development (R&D) Company Pipeline

In this section you can find business information covering life science companies' R&D pipelines. Reports can including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail, product revenue, trademarks, corporate partners and management profiles.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Pipeline


Title Sort Publication Date Sort Price Sort
place holder


Digestive System - Irritable Bowel Syndrome Drug Pipeline Report

February 2008 £1495
Digestive System - Indigestion Drug Pipeline Report

February 2008 £995
Digestive System - Nausea and Vomiting Drug Pipeline Report

February 2008 £995
Digestive System - Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Drug Pipeline Report

February 2008 £995
Digestive System - Ulcers Drug Pipeline Report

February 2008 £995
Digestive System - Ulcerative Colitis Drug Pipeline Report

February 2008 £995
Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report

February 2008 £995
Digestive System - Diarrhea Drug Pipeline Report

February 2008 £1495
Dermatology - Skin Infections or Dermatosis or Skin Itching Drug Pipeline Report

February 2008 £995
Dermatology - Eczema Drug Pipeline Report

February 2008 £995
Dermatology - Wounds or Wound Dressing Drug Pipeline Report

February 2008 £995
Digestive System - Acidity Drug Pipeline Report

February 2008 £995
Digestive System - Constipation Drug Pipeline Report

February 2008 £995
Gastrointestinal (Stomach) Cancer Drug Pipeline Report

February 2008 £995
Genetic Diseases and Dysmorphic Syndromes - Gaucher's Disease Drug Pipeline Report

February 2008 £995
Infections - Hepatitis B Drug Pipeline Report

February 2008 £1495
Infections - Helminthic Infestations Drug Pipeline Report

February 2008 £995
Infections - Hepatitis C Drug Pipeline Report

February 2008 £1495
Infections - Herpes Simplex Virus Infection Drug Pipeline Report

February 2008 £995
Infections - Influenza Drug Pipeline Report

February 2008 £1495
Infections - Fungal Infections or Candidiasis Drug Pipeline Report

February 2008 £1495
Infections - Fever Drug Pipeline Report

February 2008 £995
Head and Neck Cancer Drug Pipeline Report

February 2008 £1495
Genetic Diseases and Dysmorphic Syndromes - Turner's Syndrome Drug Pipeline Report

February 2008 £995
Infections - AIDS HIV Drug Pipeline Report

February 2008 £1495
Infections - Bacterial Infections Drug Pipeline Report

February 2008 £1495
Infections - Ear Infections Drug Pipeline Report

February 2008 £995
Dermatology - Burns Drug Pipeline Report

February 2008 £995
Dermatology - Alopecia (Hair Loss) Drug Pipeline Report

February 2008 £995
Central Nervous System - Anxiety Drug Pipeline Report

February 2008 £1495
Central Nervous System - Alzheimer Disease Drug Pipeline Report

February 2008 £1495
Central Nervous System - Dementia Drug Pipeline Report

February 2008 £995
Central Nervous System - Depression Drug Pipeline Report

February 2008 £1495
Central Nervous System - Epilepsy Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Thrombosis Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Stroke Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Intermittent Claudication Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Hypertension Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Ischemia Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Peripheral Vascular Disease Drug Pipeline Report

February 2008 £995
Central Nervous System - Headache Drug Pipeline Report

February 2008 £995
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report

February 2008 £995
Dental - Caries Drug Pipeline Report

February 2008 £995
Central Nervous System - Stroke Drug Pipeline Report

February 2008 £995
Dental - Dental - Pain Drug Pipeline Report

February 2008 £995
Dental - Gingivitis or Periodontitis Drug Pipeline Report

February 2008 £995
Dermatology - Acne Drug Pipeline Report

February 2008 £995
Central Nervous System - Seizures Drug Pipeline Report

February 2008 £995
Central Nervous System - Schizophrenia Drug Pipeline Report

February 2008 £1495
Central Nervous System - Multiple Sclerosis Drug Pipeline Report

February 2008 £1495
Central Nervous System - Migraine Drug Pipeline Report

February 2008 £1495
Central Nervous System - Neuropathy Drug Pipeline Report

February 2008 £995
Central Nervous System - Pain Drug Pipeline Report

February 2008 £1495
Central Nervous System - Parkinson Disease Drug Pipeline Report

February 2008 £1495
Infections - Malaria Drug Pipeline Report

February 2008 £995
Infections - Pneumonia Drug Pipeline Report

February 2008 £1495
Pancreatic Cancer Drug Pipeline Report

February 2008 £1495
Ovarian Cancer Drug Pipeline Report

February 2008 £1495
Prostate Cancer Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Asthma Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Report

February 2008 £1495
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report

February 2008 £995
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report

February 2008 £1495
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Cough Drug Pipeline Report

February 2008 £995
Women's Health - Female Sexual Dysfunction Drug Pipeline Report

February 2008 £995
Women's Health - Endometriosis Drug Pipeline Report

February 2008 £995
Women's Health - Infertility Drug Pipeline Report

February 2008 £995
Women's Health - Menopausal Symptoms Drug Pipeline Report

February 2008 £995
Women's Health - Vaginal Infections Drug Pipeline Report

February 2008 £995
Women's Health - Contraception Drug Pipeline Report

February 2008 £995
Substance Abuse - Smoking Cessation Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Nasal congestion Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report

February 2008 £995
Substance Abuse - Alcoholism Drug Pipeline Report

February 2008 £995
Substance Abuse - Antidote Drug Pipeline Report

February 2008 £995
Substance Abuse - Poisoning Drug Pipeline Report

February 2008 £995
Non-Hodgkin Lymphoma Drug Pipeline Report

February 2008 £1495
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report

February 2008 £1495
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report

February 2008 £995
Infections - Tuberculosis Drug Pipeline Report

February 2008 £995
Infections - Staphylococcal Infections Drug Pipeline Report

February 2008 £1495
Infections - Urinary Tract Infections Drug Pipeline Report

February 2008 £995
Infections - Viral Infections Drug Pipeline Report

February 2008 £995
Kidney Cancer Drug Pipeline Report

February 2008 £1495
Liver Cancer Drug Pipeline Report

February 2008 £995
Melanoma or Skin Cancer Drug Pipeline Report

February 2008 £1495
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report

February 2008 £1495
Multiple Myeloma Drug Pipeline Report

February 2008 £1495
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report

February 2008 £995
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Obesity Drug Pipeline Report

February 2008 £1495
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Cachexia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Hypercholesterolemia Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Bronchitis Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Lupus Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Rheumatoid Arthritis Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Transplant Rejection or Transplantation Drug Pipeline Report

February 2008 £1495
Blood and Lymphatic System - Anemia Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Inflammation - Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Crohn Disease Drug Pipeline Report

February 2008 £995
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Edema Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Allergy Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Arthritis Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Dyslipidemia Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Autoimmune Diseases Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Angina Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Electrolyte Deficiencies Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report

February 2008 £1495
Breast Cancer Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Arrhythmiasis Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Hyperlipemia Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Myelodysplastic Syndrome Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Thromboembolism Drug Pipeline Report

February 2008 £995
Novadel Pharma Inc -Detailed Product Pipeline

February 2008 £375
Novartis AG -Detailed Product Pipeline

February 2008 £375
Novacea Inc -Detailed Product Pipeline

February 2008 £375
Northwest Biotherapeutics Inc -Detailed Product Pipeline

February 2008 £375
Novavax Inc -Detailed Product Pipeline

February 2008 £375
Northfield Laboratories Inc -Detailed Product Pipeline

February 2008 £375
North American Scientific Inc -Detailed Product Pipeline

February 2008 £375
Novozymes A -Detailed Product Pipeline

February 2008 £375
Nutra Pharma Corp -Detailed Product Pipeline

February 2008 £375
Nutrition 21 Inc -Detailed Product Pipeline

February 2008 £375
Nitromed Inc -Detailed Product Pipeline

February 2008 £375
Nucryst Pharmaceuticals Corp -Detailed Product Pipeline

February 2008 £375
Novogen Ltd -Detailed Product Pipeline

February 2008 £375
Noven Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Novo -Nordisk A -Detailed Product Pipeline

February 2008 £375
Novelos Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Neose Technologies Inc -Detailed Product Pipeline

February 2008 £375
Nektar Therapeutics -Detailed Product Pipeline

February 2008 £375
NeoPharm Inc -Detailed Product Pipeline

February 2008 £375
Nuvelo Inc. -Detailed Product Pipeline

February 2008 £375
NatureWell Inc -Detailed Product Pipeline

February 2008 £375
Nastech Pharmaceutical Co Inc -Detailed Product Pipeline

February 2008 £375
Nabi Biopharmaceuticals -Detailed Product Pipeline

February 2008 £375
NanoViricides, Inc. -Detailed Product Pipeline

February 2008 £375
Neuro -Hitech Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Neurobiological Technologies Inc -Detailed Product Pipeline

February 2008 £375
NeurogesX, Inc. -Detailed Product Pipeline

February 2008 £375
Neurologix Inc -Detailed Product Pipeline

February 2008 £375
NexMed Inc -Detailed Product Pipeline

February 2008 £375
Neurogenesis Inc -Detailed Product Pipeline

February 2008 £375
Neurogen Corporation -Detailed Product Pipeline

February 2008 £375
Neurochem Inc -Detailed Product Pipeline

February 2008 £375
Neurocrine Biosciences Inc -Detailed Product Pipeline

February 2008 £375
Nile Therapeutics, Inc -Detailed Product Pipeline

February 2008 £375
Opexa Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
PDL BioPharma Inc -Detailed Product Pipeline

February 2008 £375
POZEN Inc -Detailed Product Pipeline

February 2008 £375
PacificHealth Laboratories Inc -Detailed Product Pipeline

February 2008 £375
Osteologix, Inc. -Detailed Product Pipeline

February 2008 £375
Osiris Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Orthovita Inc -Detailed Product Pipeline

February 2008 £375
Oscient Pharmaceuticals Corp -Detailed Product Pipeline

February 2008 £375
Pain Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Palatin Technologies Inc -Detailed Product Pipeline

February 2008 £375
Peregrine Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Perrigo Company -Detailed Product Pipeline

February 2008 £375
Pfizer Inc -Detailed Product Pipeline

February 2008 £375
Peplin Ltd -Detailed Product Pipeline

February 2008 £375
Penwest Pharmaceuticals Co -Detailed Product Pipeline

February 2008 £375
Panacos Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Par Pharmaceutical Companies Inc -Detailed Product Pipeline

February 2008 £375
OrthoLogic Corporation -Detailed Product Pipeline

February 2008 £375
Orexigen Therapeutics, Inc. -Detailed Product Pipeline

February 2008 £375
Oculus Innovative Sciences Inc -Detailed Product Pipeline

February 2008 £375
Omrix Biopharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
OncoVista, Inc. -Detailed Product Pipeline

February 2008 £375
OXiGENE INC -Detailed Product Pipeline

February 2008 £375
OXIS International Inc -Detailed Product Pipeline

February 2008 £375
Nymox Pharmaceutical Corporation -Detailed Product Pipeline

February 2008 £375
OSI Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Oncolytics Biotech Inc -Detailed Product Pipeline

February 2008 £375
Oncothyreon, Inc. -Detailed Product Pipeline

February 2008 £375
Oragenics Inc -Detailed Product Pipeline

February 2008 £375
Oramed Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Orchid Chemicals & Pharmaceuticals Ltd -Detailed Product Pipeline

February 2008 £375
Optimer Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Opko Health, Inc. -Detailed Product Pipeline

February 2008 £375
Onyx Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
NPS Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Nventa Biopharmaceuticals Corp -Detailed Product Pipeline

February 2008 £375
MiddleBrook Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Kosan Biosciences Incorporated -Detailed Product Pipeline

February 2008 £375
Kyto BioPharma Inc -Detailed Product Pipeline

February 2008 £375
LAM Pharmaceutical Corp -Detailed Product Pipeline

February 2008 £375
King Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Keryx Biopharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Johnson & Johnson -Detailed Product Pipeline

February 2008 £375
KV Pharmaceutical Co. -Detailed Product Pipeline

February 2008 £375
La Jolla Pharmaceutical Co -Detailed Product Pipeline

February 2008 £375
Labopharm Inc -Detailed Product Pipeline

February 2008 £375
Lexicon Pharmaceuticals, Inc -Detailed Product Pipeline

February 2008 £375
Ligand Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Lorus Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Lev Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Lescarden Inc -Detailed Product Pipeline

February 2008 £375
Lannett Co Inc -Detailed Product Pipeline

February 2008 £375
Lee Pharmaceuticals -Detailed Product Pipeline

February 2008 £375
Jazz Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Javelin Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Inovio Biomedical Corp -Detailed Product Pipeline

February 2008 £375
Insmed Incorporated -Detailed Product Pipeline

February 2008 £375
Inspire Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Innovive Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Inhibitex Inc -Detailed Product Pipeline

February 2008 £375
Infinity Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Inflazyme Pharmaceuticals Ltd. -Detailed Product Pipeline

February 2008 £375
IntelGenx Technologies Corp. -Detailed Product Pipeline

February 2008 £375
Intellect Neurosciences, Inc. -Detailed Product Pipeline

February 2008 £375
Iomai Corp -Detailed Product Pipeline

February 2008 £375
Isis Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
IsoRay Inc -Detailed Product Pipeline

February 2008 £375
Inyx Inc -Detailed Product Pipeline